Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for Hantavirus Cardiopulmonary Syndrome
NCT00128180Phase 2Completed
- Sponsor
- The University of New Mexico
- Start
- Jan 2003
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone injection in hantavirus pulmonary syndrome (HPS), sponsored by The University of New Mexico. Started Jan 2003; status: completed.
02
Drugs
methylprednisolone injection
03
Conditions
hantavirus pulmonary syndrome (HPS)
Beyond the preview
Go deeper on NCT00128180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128180.